Kidney & Renal Cancer Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: KA8EF5260F61EN
Market Monitor Global

Abstracts

Kidney/Renal Cancer Drugs are used to cure kidney cancers.

This report contains market size and forecasts of Kidney & Renal Cancer Drugs in global, including the following market information:

Global Kidney & Renal Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Kidney & Renal Cancer Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Kidney & Renal Cancer Drugs companies in 2021 (%)

The global Kidney & Renal Cancer Drugs market was valued at 4561 million in 2021 and is projected to reach US$ 5582.9 million by 2028, at a CAGR of 2.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Kidney & Renal Cancer Drugs include F. Hoffmann, Bayer, Pfizer and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney & Renal Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Kidney & Renal Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney & Renal Cancer Drugs Market Segment Percentages, by Type, 2021 (%)

• Targeted Therapy
• Chemotherapy
• Immunotherapy

Global Kidney & Renal Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney & Renal Cancer Drugs Market Segment Percentages, by Application, 2021 (%)

• Drug Manufacturers
• Hospitals and Clinics
• Private and Government Research Institutes
• Academic Institutes

Global Kidney & Renal Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney & Renal Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Kidney & Renal Cancer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Kidney & Renal Cancer Drugs revenues share in global market, 2021 (%)

Key companies Kidney & Renal Cancer Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Kidney & Renal Cancer Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann
• Bayer
• Pfizer
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Kidney & Renal Cancer Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Kidney & Renal Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KIDNEY & RENAL CANCER DRUGS OVERALL MARKET SIZE

2.1 Global Kidney & Renal Cancer Drugs Market Size: 2021 VS 2028
2.2 Global Kidney & Renal Cancer Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Kidney & Renal Cancer Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Kidney & Renal Cancer Drugs Players in Global Market
3.2 Top Global Kidney & Renal Cancer Drugs Companies Ranked by Revenue
3.3 Global Kidney & Renal Cancer Drugs Revenue by Companies
3.4 Global Kidney & Renal Cancer Drugs Sales by Companies
3.5 Global Kidney & Renal Cancer Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Kidney & Renal Cancer Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Kidney & Renal Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney & Renal Cancer Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Kidney & Renal Cancer Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Kidney & Renal Cancer Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Kidney & Renal Cancer Drugs Market Size Markets, 2021 & 2028
  4.1.2 Targeted Therapy
  4.1.3 Chemotherapy
  4.1.4 Immunotherapy
4.2 By Type - Global Kidney & Renal Cancer Drugs Revenue & Forecasts
  4.2.1 By Type - Global Kidney & Renal Cancer Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Kidney & Renal Cancer Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Kidney & Renal Cancer Drugs Sales & Forecasts
  4.3.1 By Type - Global Kidney & Renal Cancer Drugs Sales, 2017-2022
  4.3.2 By Type - Global Kidney & Renal Cancer Drugs Sales, 2023-2028
  4.3.3 By Type - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Kidney & Renal Cancer Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Kidney & Renal Cancer Drugs Market Size, 2021 & 2028
  5.1.2 Drug Manufacturers
  5.1.3 Hospitals and Clinics
  5.1.4 Private and Government Research Institutes
  5.1.5 Academic Institutes
5.2 By Application - Global Kidney & Renal Cancer Drugs Revenue & Forecasts
  5.2.1 By Application - Global Kidney & Renal Cancer Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Kidney & Renal Cancer Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Kidney & Renal Cancer Drugs Sales & Forecasts
  5.3.1 By Application - Global Kidney & Renal Cancer Drugs Sales, 2017-2022
  5.3.2 By Application - Global Kidney & Renal Cancer Drugs Sales, 2023-2028
  5.3.3 By Application - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Kidney & Renal Cancer Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Kidney & Renal Cancer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Kidney & Renal Cancer Drugs Revenue & Forecasts
  6.2.1 By Region - Global Kidney & Renal Cancer Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Kidney & Renal Cancer Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Kidney & Renal Cancer Drugs Sales & Forecasts
  6.3.1 By Region - Global Kidney & Renal Cancer Drugs Sales, 2017-2022
  6.3.2 By Region - Global Kidney & Renal Cancer Drugs Sales, 2023-2028
  6.3.3 By Region - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Kidney & Renal Cancer Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Kidney & Renal Cancer Drugs Sales, 2017-2028
  6.4.3 US Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.4.4 Canada Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.4.5 Mexico Kidney & Renal Cancer Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Kidney & Renal Cancer Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Kidney & Renal Cancer Drugs Sales, 2017-2028
  6.5.3 Germany Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.4 France Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.5 U.K. Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.6 Italy Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.7 Russia Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.5.9 Benelux Kidney & Renal Cancer Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Kidney & Renal Cancer Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Kidney & Renal Cancer Drugs Sales, 2017-2028
  6.6.3 China Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.6.4 Japan Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.6.5 South Korea Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.6.7 India Kidney & Renal Cancer Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Kidney & Renal Cancer Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Kidney & Renal Cancer Drugs Sales, 2017-2028
  6.7.3 Brazil Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.7.4 Argentina Kidney & Renal Cancer Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Kidney & Renal Cancer Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Kidney & Renal Cancer Drugs Sales, 2017-2028
  6.8.3 Turkey Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.8.4 Israel Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Kidney & Renal Cancer Drugs Market Size, 2017-2028
  6.8.6 UAE Kidney & Renal Cancer Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 F. Hoffmann
  7.1.1 F. Hoffmann Corporate Summary
  7.1.2 F. Hoffmann Business Overview
  7.1.3 F. Hoffmann Kidney & Renal Cancer Drugs Major Product Offerings
  7.1.4 F. Hoffmann Kidney & Renal Cancer Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 F. Hoffmann Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Kidney & Renal Cancer Drugs Major Product Offerings
  7.2.4 Bayer Kidney & Renal Cancer Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Bayer Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Kidney & Renal Cancer Drugs Major Product Offerings
  7.3.4 Pfizer Kidney & Renal Cancer Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Kidney & Renal Cancer Drugs Major Product Offerings
  7.4.4 Novartis Kidney & Renal Cancer Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News

8 GLOBAL KIDNEY & RENAL CANCER DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Kidney & Renal Cancer Drugs Production Capacity, 2017-2028
8.2 Kidney & Renal Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney & Renal Cancer Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 KIDNEY & RENAL CANCER DRUGS SUPPLY CHAIN ANALYSIS

10.1 Kidney & Renal Cancer Drugs Industry Value Chain
10.2 Kidney & Renal Cancer Drugs Upstream Market
10.3 Kidney & Renal Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Kidney & Renal Cancer Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Kidney & Renal Cancer Drugs in Global Market
Table 2. Top Kidney & Renal Cancer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Kidney & Renal Cancer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Kidney & Renal Cancer Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Kidney & Renal Cancer Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Kidney & Renal Cancer Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Kidney & Renal Cancer Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Kidney & Renal Cancer Drugs Product Type
Table 9. List of Global Tier 1 Kidney & Renal Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney & Renal Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Kidney & Renal Cancer Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Kidney & Renal Cancer Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Kidney & Renal Cancer Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Kidney & Renal Cancer Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Kidney & Renal Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Kidney & Renal Cancer Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Kidney & Renal Cancer Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Kidney & Renal Cancer Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Kidney & Renal Cancer Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Kidney & Renal Cancer Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Kidney & Renal Cancer Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Kidney & Renal Cancer Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Kidney & Renal Cancer Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Kidney & Renal Cancer Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Kidney & Renal Cancer Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Sales, (K Units), 2023-2028
Table 46. F. Hoffmann Corporate Summary
Table 47. F. Hoffmann Kidney & Renal Cancer Drugs Product Offerings
Table 48. F. Hoffmann Kidney & Renal Cancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bayer Corporate Summary
Table 50. Bayer Kidney & Renal Cancer Drugs Product Offerings
Table 51. Bayer Kidney & Renal Cancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Kidney & Renal Cancer Drugs Product Offerings
Table 54. Pfizer Kidney & Renal Cancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Kidney & Renal Cancer Drugs Product Offerings
Table 57. Novartis Kidney & Renal Cancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Kidney & Renal Cancer Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Kidney & Renal Cancer Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Kidney & Renal Cancer Drugs Production by Region, 2017-2022 (K Units)
Table 61. Global Kidney & Renal Cancer Drugs Production by Region, 2023-2028 (K Units)
Table 62. Kidney & Renal Cancer Drugs Market Opportunities & Trends in Global Market
Table 63. Kidney & Renal Cancer Drugs Market Drivers in Global Market
Table 64. Kidney & Renal Cancer Drugs Market Restraints in Global Market
Table 65. Kidney & Renal Cancer Drugs Raw Materials
Table 66. Kidney & Renal Cancer Drugs Raw Materials Suppliers in Global Market
Table 67. Typical Kidney & Renal Cancer Drugs Downstream
Table 68. Kidney & Renal Cancer Drugs Downstream Clients in Global Market
Table 69. Kidney & Renal Cancer Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Kidney & Renal Cancer Drugs Segment by Type
Figure 2. Kidney & Renal Cancer Drugs Segment by Application
Figure 3. Global Kidney & Renal Cancer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Kidney & Renal Cancer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Kidney & Renal Cancer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Kidney & Renal Cancer Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney & Renal Cancer Drugs Revenue in 2021
Figure 9. By Type - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Kidney & Renal Cancer Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Kidney & Renal Cancer Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 19. US Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 24. Germany Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 33. China Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Kidney & Renal Cancer Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Kidney & Renal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Kidney & Renal Cancer Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Kidney & Renal Cancer Drugs by Region, 2021 VS 2028
Figure 50. Kidney & Renal Cancer Drugs Industry Value Chain
Figure 51. Marketing Channels